生长因子受体作为单克隆抗体抗肿瘤治疗的靶点。 - Suppr

Suppr

超能文献

Growth factor receptors as targets for antitumor therapy with monoclonal antibodies.

作者信息

Mendelsohn J

出版信息

Prog Allergy. 1988;45:147-60. doi: 10.1159/000416378.

DOI:10.1159/000416378

PMID:3064094

Abstract

摘要

相似文献

Growth factor receptors as targets for antitumor therapy with monoclonal antibodies.生长因子受体作为单克隆抗体抗肿瘤治疗的靶点。

Prog Allergy. 1988;45:147-60. doi: 10.1159/000416378.

Cytosine arabinoside increases the binding of 125I-labelled epidermal growth factor and 125I-transferrin and enhances the in vitro targeting of human tumour cells with anti-(growth factor receptor) mAb.阿糖胞苷增加了¹²⁵I标记的表皮生长因子和¹²⁵I转铁蛋白的结合，并增强了抗（生长因子受体）单克隆抗体对人肿瘤细胞的体外靶向作用。

Cancer Immunol Immunother. 1993 Aug;37(3):150-6. doi: 10.1007/BF01525428.

Transferrin receptor as a potential therapeutic target.

Prog Allergy. 1988;45:121-46. doi: 10.1159/000416377.

Growth factor receptor monoclonal antibodies and cancer immunotherapy.生长因子受体单克隆抗体与癌症免疫疗法。

J Natl Cancer Inst. 1989 Nov 1;81(21):1600-1. doi: 10.1093/jnci/81.21.1600.

EGF mutant receptor vIII as a molecular target in cancer therapy.表皮生长因子（EGF）突变受体vIII作为癌症治疗中的分子靶点。

Endocr Relat Cancer. 2001 Jun;8(2):83-96. doi: 10.1677/erc.0.0080083.

In vivo diagnosis and therapy of human tumors with monoclonal antibodies: selection of antibodies and preliminary clinical studies in small cell carcinoma of the lung.单克隆抗体在人类肿瘤的体内诊断与治疗：抗体的选择及在小细胞肺癌中的初步临床研究

Int J Rad Appl Instrum B. 1989;16(2):159-62. doi: 10.1016/0883-2897(89)90189-x.

[New developments in immunotherapy for digestive system diseases].[消化系统疾病免疫治疗的新进展]

Nihon Naika Gakkai Zasshi. 2005 Sep 10;94(9):1901-7. doi: 10.2169/naika.94.1901.

[Combined anti-EGFR and anti-HER2 monoclonal antibodies: preclinical efficacy in the treatment of pancreatic cancer].[联合抗表皮生长因子受体（EGFR）和抗人表皮生长因子受体2（HER2）单克隆抗体：胰腺癌治疗的临床前疗效]

Med Sci (Paris). 2007 Oct;23(10):800-3. doi: 10.1051/medsci/20072310800.

The interleukin-2 receptor: a target for immunotherapy.

Ann N Y Acad Sci. 1993 Jun 23;685:603-10. doi: 10.1111/j.1749-6632.1993.tb35923.x.

Monoclonal antibodies directed at growth factor receptors.针对生长因子受体的单克隆抗体。

Ann Oncol. 2000;11 Suppl 3:187-90. doi: 10.1093/annonc/11.suppl_3.187.

引用本文的文献

Heterogeneity response to afatinib in gastric cancer patient with uncommon epidermal growth factor receptor (EGFR) mutations: a case report.具有罕见表皮生长因子受体（EGFR）突变的胃癌患者对阿法替尼的异质性反应：一例报告

Ann Transl Med. 2021 May;9(9):814. doi: 10.21037/atm-20-7312.

[Observation - An Favorable Option Forthoracic Dissemination Patients with Lung Adenocarcinoma or Squamous Carcinoma].[观察——肺腺癌或肺鳞癌胸内播散患者的一种有利选择]

Zhongguo Fei Ai Za Zhi. 2018 Apr 20;21(4):303-309. doi: 10.3779/j.issn.1009-3419.2018.04.14.

Head and neck cancer: an evolving treatment paradigm.头颈癌：一种不断演变的治疗模式。

Cancer. 2008 Oct 1;113(7 Suppl):1911-32. doi: 10.1002/cncr.23654.

Therapeutic potential of chimeric and murine anti-(epidermal growth factor receptor) antibodies in a metastasis model for human melanoma.嵌合抗体和鼠抗（表皮生长因子受体）抗体在人黑色素瘤转移模型中的治疗潜力

Cancer Immunol Immunother. 1993 Oct;37(5):343-9. doi: 10.1007/BF01518458.

Cancer Immunol Immunother. 1993 Aug;37(3):150-6. doi: 10.1007/BF01525428.

The biotechnology and applications of antibody engineering.抗体工程的生物技术及其应用

Mol Biotechnol. 1995 Apr;3(2):139-54. doi: 10.1007/BF02789110.

Effects of 131I-EGF on cultured human glioma cells.131I-表皮生长因子对培养的人胶质瘤细胞的影响。

J Neurooncol. 1990 Dec;9(3):201-10. doi: 10.1007/BF02341150.

Effects of EGF-dextran-tyrosine-131I conjugates on the clonogenic survival of cultured glioma cells.表皮生长因子-葡聚糖-酪氨酸-131I 偶联物对培养的胶质瘤细胞克隆形成存活率的影响。

J Neurooncol. 1992 Nov;14(3):213-23. doi: 10.1007/BF00172597.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验